Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S14 pseudogene 5 (RPS14P5) is a processed pseudogene mapped in the human genome. Pseudogenes are DNA sequences similar to known genes but generally lack the ability to encode a functional protein, often due to mutations or deletions. RPS14P5 shares high sequence homology with the functional ribosomal protein S14 (RPS14) gene, which is an essential component of the small ribosomal subunit involved in protein synthesis. However, unlike RPS14, RPS14P5 is not translated into a protein, is not known to participate in cell physiology, and has not been implicated in disease or therapeutic interactions. Its significance lies primarily as a genomic relic of gene duplication or retrotransposition, rather than as a functional molecular target. Key distinctions: RPS14P5 is not a protein, target, or biomarker; it is a non-coding pseudogene. Some databases may list it under ribosomal protein families due to sequence similarity, but its functional relevance is null.
None. There are no drug mechanisms of action targeting RPS14P5.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S14 pseudogene 5 (RPS14P5).